Pediatric Medicine for the Child Psychiatrist

  • Amanda Schroepfer O’KellyEmail author


A functional knowledge of general pediatric principles is essential for pediatric consultation-liaison (C-L) providers. While a review of the full breadth of pediatrics is beyond the scope of this textbook, this chapter endeavors to cull relevant issues often encountered in a pediatric C-L service and to examine them through a general pediatrics lens. Familiarity with the pediatrician’s rationale and approach adds depth to the pediatric C-L providers’ care and provides insight and allows for more collaboration with pediatric colleagues. Links and references to convenient charts, tables, and patient handouts are provided throughout the chapter. Current treatment guidelines (e.g., for obesity and diabetes), with acknowledgement that they can and will change over time, are referenced with links to principal regulating agencies for the most up-to-date information available to the reader.


General pediatrics Consultation-liaison child psychiatry Growth Vital signs Development nutrition 


  1. Almandil, N., et al. (2013). Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: A systematic review and meta-analysis. Paediatric Drugs, 15(2), 139–150. Scholar
  2. American Diabetes Association. (2016). Standards of medical care in diabetes—2016. Diabetes Care, 39(suppl 1), S1–S106.Google Scholar
  3. Care for transgender adolescents. (2017). Committee opinion no. 685. American College of Obstetricians and Gynecologists. Obstetrics and Gynecology, 129, e11–e16.Google Scholar
  4. Correll, C., & Carlson, H. (2006). Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 771–791.CrossRefGoogle Scholar
  5. Correll, C. U., et al. (2009). Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. Journal of the American Medical Association, 302(16), 1765–1773.CrossRefGoogle Scholar
  6. Dietary Guidelines for Americans. (2005).
  7. Dori, N. & Green, T. (2011, October). The metabolic syndrome and antipsychotics in children and adolescents. Harefuah, 150(10), 791–796, 814, 813.Google Scholar
  8. Falkner, B. (2010). Hypertension in children and adolescents: Epidemiology and natural history. Pediatric Nephrology, 25(7), 1219–1224.CrossRefGoogle Scholar
  9. George, M. et al. (2014). Hypertension screening in children and adolescents – National Ambulatory Medical Care Survey, National Hospital Ambulatory Medical Care Survey, and Medical Expenditure Panel Survey, United States, 2007–2010. MMWR Supplements September 12, 2014/63(02), 47–53.Google Scholar
  10. Goeb, J. L., et al. (2010). Metabolic side effects of risperidone in early onset schizophrenia. Encephale, 36(3), 242–252. Epub 2009 Dec 1.CrossRefGoogle Scholar
  11. Hembree, W., et al. (2017). Endocrine treatment of gender-dysphoric/gender-incongruent persons: An endocrine society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 102(11), 3869–3903. Scholar
  12. Human Rights Campaign, AAP. (2017). Supporting and caring for transgender children. September 2016.
  13. Loy, J. H., et al. (2017). Atypical antipsychotics for disruptive behaviour disorders in children and youths. Cochrane Database of Systematic Reviews, 8, CD008559. Epub 2017 Aug 9.PubMedGoogle Scholar
  14. Overbeek, W. A., et al. (2010). Antipsychotics and metabolic abnormalities in children and adolescents: A review of the literature and some recommendations. Tijdschrift voor Psychiatrie, 52(5), 311–320.PubMedGoogle Scholar
  15. Strickland, B. B., et al. (2004). Access to the medical home: Results of the national survey of children with special healthcare needs. Pediatrics, 113, 1485–1492. Scholar
  16. Uddin, S. et al. (2016, May). Physician office visits by children for well and problem-focused care: United States, 2012. CDC NCHS Data Brief No. 248.Google Scholar
  17. Wilmot, E., & Idris, I. (2014). Early onset type 2 diabetes: Risk factors, clinical impact and management. Therapeutic Advances in Chronic Disease., 5(6), 234–244. Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Departments of Psychiatry & PediatricsUH-JABSOMHonoluluUSA

Personalised recommendations